Managerial and Economic Evaluation of Small Animal Veterinary Clinics in Ankara Province of Turkey


ARAL Y., CEVGER Y., Demir P., Aydin E.

KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI, cilt.16, sa.3, ss.503-508, 2010 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 16 Sayı: 3
  • Basım Tarihi: 2010
  • Dergi Adı: KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.503-508
  • Ankara Üniversitesi Adresli: Evet

Özet

This research aimed to identify the choice of location and operating period problems of the private veterinary clinics which focused on pet animals in an urban area of Ankara province, to analyze the financial and economic structure of these enterprises, and to provide some suggestions to solve the problems about clinic management. In this context, face-to-face surveys were conducted with a total 32 clinic owner veterinarians who agreed to participate in the study. The three factors with greatest influence on the selection of enterprise location were identified as regional animal population, household income level in the district, the number of clinics, and their proximity to each other, respectively. The average establishment cost and the return on investment period of the veterinary clinics for the year 2008 were found to be US$24.907 and 18.9 months, respectively. The average monthly cost of the veterinary clinics was calculated as US$3.155 and the expense elements with the greatest share in total cost were determined as labor cost (24.77%), vaccination-serum-drug costs (20.87%), rental expense (14.17%), and the expenses related to materials, devices and equipment (11.37%). On the other hand, the average net profit of the veterinary clinics was found to be US$2.128, while their average monthly income was US$5.283. Furthermore, the most important items in the total income of the veterinary clinics were identified as vaccinations and anti-parasitic drug therapy (26.07%), examination-treatment fees (20.66%), and surgery revenues (12.59%), respectively.